Ipatasertib

CAS: 1001264-89-6

Ref. 3D-FC43222

Información del producto

• Nombre: Ipatasertib
• Sinónimos: (S)-2-(4-Chlorophenyl)-1-(4-((5R,7R)-7-hydroxy-5-methyl-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-yl)piperazin-1-yl)-3-(isopropylamino )propan-1-one, 1-Propanone, 2-(4-chlorophenyl)-1-[4-[(5R,7R)-6,7-dihydro-7-hydroxy-5-methyl-5H-cyclopentapyrimidin-4-yl]-1-piperazinyl]-3-[(1-methylethyl)amino]-, (2S)-, Gdc-0068, Rg 7440, Rg7440, (2S)-2-(4-Chlorophenyl)-1-[4-[(5R,7R)-6,7-dihydro-7-hydroxy-5-methyl-5H-cyclopentapyrimidin-4-yl]-1-piperazinyl]-3-[(1-methylethyl)amino]-1-propanone, (2s)-2-(4-chlorophenyl)-1-(4-((5r,7r)-6,7-dihydro-7-hydroxy-5-methyl-5h-cyclopentapyrimidin-4-yl)-1-piperazinyl)-3-((1-methylethyl)amino)-1-propanone

Descripción

Ipatasertib is a drug that belongs to the class of inhibitors of the ATP-binding cassette (ABC) transporter protein P-glycoprotein. It prevents the efflux of drugs from cancer cells, thereby increasing their concentration in tumor tissue. Ipatasertib has been shown to be effective against eye disorders with minimal toxicity in vitro and in vivo. The drug binds to the bicylcic heterocycle as a result of its activity as an ATPase inhibitor and blocks tumor growth by inhibiting receptor activity.

• Marca: Biosynth

Propiedades químicas

• Peso molecular: 458 g/mol
• Fórmula: C₂₄H₃₂ClN₅O₂
• Pureza: Min. 95%